Are you connecting with your customers?
July 30, 2007Sales and Marketing customers, marketing
Insights (or customer insights) seems to be the current buzzword in the pharmaceutical industry. But is it something we should …
Latest news from Datamonitor
July 27, 2007Research and Development, Sales and Marketing
BioMS's multiple sclerosis trial gets positive reviewBioMS Medical's relapsing-remitting multiple sclerosis trial has received a positive review from the data …
AstraZeneca to make further job cuts
July 26, 2007Sales and Marketing
Thousands of employees in sales, marketing, R&D and back office staff will lose their jobs at AstraZeneca as the pharma …
Animal rights attacks fall to new low
July 26, 2007Sales and Marketing
Attacks by animal rights extremists in the UK have dropped to a new low – but the pharmaceutical industry says …
Avandia safety scare costs GSK $200m
July 26, 2007Sales and Marketing GSK
GlaxoSmithKline saw its performance in the second quarter of this year badly affected by a 22% slump in sales of …
Johnson defends NHS reform plans to MPs
July 26, 2007The health secretary Alan Johnson has defended his decision to carry out a once-in-a-generation reform of the NHS in England.He …
Renewed push for private sector to challenge traditional GPs
July 25, 2007The government is to ask the NHS managers to look again at using the private sector to improve primary care …
GSK’s Cervarix gets European green light
July 25, 2007Sales and Marketing
Cervarix, the cervical cancer vaccine from GlaxoSmithKline has received a positive opinion from the European medicines regulator, meaning it could …
Lilly expands UK research lab
July 23, 2007Research and Development
Lilly has opened a new extension to its UK drug research laboratories which specialise in new medicines for neurological conditions.The …
Latest news from Datamonitor
July 23, 2007Research and Development, Sales and Marketing
Affiris begins clinical testing of Alzheimer's vaccineAffiris' Alzheimer's vaccine Affitope has now entered the clinical phase of its development and …
Mood swings: the ups and downs of moving jobs
July 23, 2007Business Services career, planning, recruitment
How many times do you come across that old cliche about an emotional rollercoaster? It seems to be applied to …
Lipitor woes take toll on Pfizer
July 19, 2007Sales and Marketing
Sales of Pfizer's flagship brand Lipitor suffered in the second quarter, contributing to a 20% drop in profits.The company began …
Woman wins court battle for Avastin treatment
July 19, 2007Sales and Marketing NICE, avastin
A woman with bowel cancer has won her High Court battle for access to the drug Avastin, overturning a decision …
Spending pushes Actelion into loss but boom continues
July 19, 2007Sales and Marketing
Specialist pharma company Actelion has registered a loss of 53 million Swiss francs ($44 million) for the first half of …
Roche splits top roles
July 19, 2007Sales and Marketing
Roche's Franz Humer is stepping down as chief executive to concentrate on his role as chairman.In splitting the top jobs, …
Generic pressure curbs Novartis growth
July 17, 2007Sales and Marketing
Swiss pharma company Novartis has posted sales growth of 14% for the first half of 2007, but growing pressure from …
Doctors defy NICE as Alzheimer’s spending rises
July 17, 2007Sales and Marketing
UK Alzheimer's patients may not lose access to drug treatment, despite restrictive NICE guidance.Prescribing of Alzheimer's drugs has increased by …
Newly merged Bayer Schering launched in the UK
July 17, 2007Sales and Marketing
Bayer has officially launched its new UK pharmaceutical division, following last year's acquisition of Schering Health Care.Called Bayer Schering Pharma, …
A guarded yes to Gardasil – and a door open to Cervarix
July 17, 2007Sales and Marketing
After 18 months of deliberation by an expert committee, the UK government has agreed in principle that girls aged 12-13 …
Doctors free to overrule NICE decisions, claims charity
July 17, 2007A patient group is urging doctors to exercise their clinical judgement to overrule NICE guidance which restricts access to Alzheimer's …
Latest content
FibroFind appoints Lee Borthwick as CEO
